Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ford

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Open Heart|June 24, 2016
A cardiovascular disease policy model: part 2-preparing for economic evaluation and to assess health inequalitiesK D Lawson, J D Lewsey, I Ford, et al.
Heart (British Cardiac Society)|October 18, 2014
A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivationJ D Lewsey, K D Lawson, I Ford, et al.
BMJ (Clinical Research Ed.)|September 29, 2001
Randomised controlled trial of specialist nurse intervention in heart failureL Blue, E Lang, J J McMurray, et al.
The New England Journal of Medicine|October 19, 2000
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study GroupC J Packard, D S O'Reilly, M J Caslake, et al.
Neurology|May 25, 2005
Effect of pravastatin on cerebral infarcts and white matter lesionsV H ten Dam, D M J van den Heuvel, M A van Buchem, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Open Heart|June 24, 2016
A cardiovascular disease policy model: part 2-preparing for economic evaluation and to assess health inequalitiesK D Lawson, J D Lewsey, I Ford, et al.
Heart (British Cardiac Society)|October 18, 2014
A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivationJ D Lewsey, K D Lawson, I Ford, et al.
BMJ (Clinical Research Ed.)|September 29, 2001
Randomised controlled trial of specialist nurse intervention in heart failureL Blue, E Lang, J J McMurray, et al.
The New England Journal of Medicine|October 19, 2000
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study GroupC J Packard, D S O'Reilly, M J Caslake, et al.
Neurology|May 25, 2005
Effect of pravastatin on cerebral infarcts and white matter lesionsV H ten Dam, D M J van den Heuvel, M A van Buchem, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
Pageof 16